SOURCE: NexMed, Inc.

June 13, 2006 11:15 ET

NexMed to Present at BIO Venture Forum East 2006

EAST WINDSOR, NJ -- (MARKET WIRE) -- June 13, 2006 --NexMed, Inc. (NASDAQ: NEXM), a developer of innovative transdermal treatments based on the NexACT® drug delivery technology, today announced that Mark Westgate, Vice President and Chief Financial Officer, will present at the BIO Venture Forum East 2006 on Wednesday, June 14, 2006 at The Hyatt Regency in Jersey City, New Jersey at 2:00 p.m. Eastern Time in the Palisades Ballroom.

The BIO Venture Forum East 2006 conference brings institutional investors together with promising early and late-stage biopharmaceutical companies from the East Coast.

Commenting on his presentation, Mr. Westgate stated, "I look forward to providing an overview of our corporate goals, including potential product licensing opportunities and our product development and commercialization strategy."

About NexMed, Inc.

NexMed, an innovative drug developer, offers large pharmaceutical companies the opportunity to save considerably on R&D costs, develop new patient-friendly transdermal products, and extend patent lifespans and brand equity, through participation in early stage licensing and development partnerships. NexMed currently has a host of medicines in development, such as treatments for nail fungus, sexual disorders and more, all based on its proprietary NexACT® drug delivery technology.

Contact Information

  • Company Contact:
    Deborah Carty
    NexMed, Inc.
    (609) 371-8123, ext: 159
    Email Contact

    Investor Relations:
    Melody Carey
    Rx Communications Group, LLC
    (917) 322-2568
    Email Contact